On the other hand, it is also possible that the reduced GLT-1 expression, in addition to the diminished glutamate uptake13,14 may affect the PS1-dependent amyloid precursor protein (APP) processing due to diminished PS1-GLT-1 interaction, thus contributing to AD pathology. Here, SLC1A2 is linked to Alzheimer disease.